<![CDATA[Jean Boulle Group 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=24789>Thu, 14 May 2026 10:09:14 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Jean Boulle Group, ‘Tendyne 경피적 승모판막’ 유럽연합 승인 획득]]>https://www.newswire.co.kr/newsRead.php?no=900911Fri, 07 Feb 2020 09:13:38 +0900<![CDATA[Jean Boulle Group - US$250 Million+ Abbott Laboratories Acquisition of Tendyne Holdings Mitral Valve Company Confirms the Group’s Pedigree for Making Serial Major Discoveries from Mines to Medical technology.]]>https://www.newswire.co.kr/newsRead.php?no=802967Wed, 09 Sep 2015 17:55:00 +0900<![CDATA[장불그룹, 2억 5000만 달러 + 애보트 래보러토리즈의 텐다인 홀딩스 승모판 회사 인수…광업에서 의료 기술까지 일련의 주요 발견을 만들어내는 그룹 계보 확인]]>https://www.newswire.co.kr/newsRead.php?no=802968Wed, 09 Sep 2015 17:55:00 +0900<![CDATA[Jean Boulle Group Announces First US Clinical Trial]]>https://www.newswire.co.kr/newsRead.php?no=790122Mon, 27 Apr 2015 13:40:00 +0900<![CDATA[장불그룹, 첫 미국 임상 시험 발표]]>https://www.newswire.co.kr/newsRead.php?no=790124Mon, 27 Apr 2015 13:40:00 +0900